O60673 (REV3L_HUMAN) Homo sapiens (Human)
DNA polymerase zeta catalytic subunit UniProtKBInterProSTRINGInteractive Modelling
3130 aa; Sequence (Fasta) ; (Isoform 2)
It is possible new templates exist for this target since these models were created.
Available Structures
13 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of Rev7-K44A/R124A/A135D in complex with Rev3-RBM2 (residues 1988-2014) |
Heteromer Q9UI95; | |||||
| Assess | ||||||
| Crystal structure of Rev7-R124A/Rev3-RBM2 (residues 1988-2014) complex |
Heteromer Q9UI95; | 2×SO4; 2×ACT; | ||||
| Assess | ||||||
| Crystal structure of mammalian Rev7 in complex with human Rev3 second binding site |
Heteromer Q9D752; | |||||
| Assess | ||||||
| Structure of polymerase-interacting domain of human Rev1 in complex with translesional synthesis po… |
Heteromer Q9UBZ9; Q9UI95; | |||||
| Assess | ||||||
| Crystal structure of Rev7-WT/Rev3 as a monomer under high-salt conditions |
Heteromer Q9UI95; | |||||
| Assess | ||||||
| Crystal structure of mammalian Rev7 in complex with Rev3 1875-1895 |
Heteromer Q9D752; | |||||
| Assess | ||||||
| Structure of human REV7 in complex with a human REV3 fragment in a monoclinic crystal |
Heteromer Q9UI95; | |||||
| Assess | ||||||
| Rational drug design of phenazopyridine derivatives as novel inhibitors of Rev1-CT |
Heteromer Q9UBZ9; Q9UI95; | 1×U8M; | ||||
| Assess | ||||||
| Structure of human REV7 in complex with a human REV3 fragment in a tetragonal crystal |
Heteromer Q9UI95; | |||||
| Assess | ||||||
| Crystal structure of REV1-REV7-REV3 ternary complex |
Heteromer Q9UBZ9; Q9UI95; | |||||
| Assess | ||||||
| Rational drug design of phenazopyridine derivatives as novel inhibitors of Rev1-CT |
Heteromer Q9UBZ9; Q9UI95; | |||||
| Assess | ||||||
| Crystal structure of human Rev3-Rev7-Rev1 complex |
Heteromer Q9UBZ9; Q9UI95; | |||||
| Assess | ||||||
| Crystal structure of human Rev3-Rev7-Rev1-Polkappa complex |
Heteromer Q9UBT6; Q9UBZ9; Q9UI95; | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 6v93.1.A | monomer | 0.63 | 1×CA; | 38.45 | ||
| Assess | ||||||
| 5iud.1.A | monomer | 0.50 | 22.13 | |||
| Assess | ||||||
4 SWISS-MODEL models built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 6v93.1.A | monomer | 0.63 | 1×CA; | 38.45 | |
| Assess | ||||||
| Isoform 2 | 7kc0.1.D | monomer | 0.56 | 28.02 | ||
| Assess | ||||||
| Isoform 2 | 5iud.1.A | monomer | 0.51 | 22.13 | ||
| Assess | ||||||
| Isoform 2 | 7kc0.1.D | monomer | 0.51 | 30.17 | ||
| Assess | ||||||